AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $304,000 | +130.3% | 862,168 | +367.4% | 0.00% | – |
Q1 2022 | $132,000 | -28.6% | 184,465 | +125.6% | 0.00% | – |
Q4 2021 | $185,000 | -11.9% | 81,774 | +12.4% | 0.00% | – |
Q3 2021 | $210,000 | +296.2% | 72,770 | +419.1% | 0.00% | – |
Q2 2021 | $53,000 | -60.2% | 14,019 | -64.3% | 0.00% | – |
Q1 2021 | $133,000 | -76.2% | 39,248 | -80.4% | 0.00% | -100.0% |
Q4 2020 | $560,000 | -39.3% | 200,093 | -45.5% | 0.00% | -50.0% |
Q3 2020 | $922,000 | -70.4% | 367,286 | +60.3% | 0.00% | -60.0% |
Q2 2020 | $3,111,000 | +89.0% | 229,059 | +5.5% | 0.01% | +66.7% |
Q1 2020 | $1,646,000 | -12.4% | 217,123 | -27.0% | 0.00% | +50.0% |
Q4 2019 | $1,880,000 | +434.1% | 297,479 | +231.4% | 0.00% | – |
Q3 2019 | $352,000 | +551.9% | 89,771 | +701.8% | 0.00% | – |
Q2 2019 | $54,000 | -75.0% | 11,196 | -50.5% | 0.00% | – |
Q1 2018 | $216,000 | -63.5% | 22,622 | -43.2% | 0.00% | -100.0% |
Q4 2017 | $592,000 | -41.7% | 39,831 | -22.8% | 0.00% | 0.0% |
Q3 2017 | $1,015,000 | – | 51,616 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |